Suchergebnisse - "Di Nisio, Marcello"

PubPharm (15)

1

Apixaban thromboprophylaxis in ambulatory patients with cancer and obesity : Insights from the AVERT trial

enthalten in: Thrombosis research | 2023

von Potere, N. | Di Nisio, M. | Porreca, E. | +7

2

Rivaroxaban treatment for six weeks versus three months in patients with symptomatic isolated distal deep vein thrombosis : randomised controlled trial

enthalten in: BMJ (Clinical research ed.) | 2022

von Ageno, W. | Bertù, L. | Bucherini, E. | +43

CommentIn: Ann Intern Med. 2023 Apr;176(4):JC42. - PMID 37011394

3

Risk factors for gastrointestinal bleeding in patients with gastrointestinal cancer using edoxaban

enthalten in: Journal of thrombosis and haemostasis : JTH | 2021

von Bosch, F. | Mulder, F. | Huisman, M. | +15

4

Clinical implications of incidental venous thromboembolism in cancer patients

enthalten in: The European respiratory journal | 2020

von Mulder, F. | Di Nisio, M. | Ay, C. | +14

CommentIn: Eur Respir J. 2020 Feb 6;55(2):. - PMID 32029648

5

Clinical Impact of Bleeding in Cancer-Associated Venous Thromboembolism : Results from the Hokusai VTE Cancer Study

enthalten in: Thrombosis and haemostasis | 2018

von Kraaijpoel, N. | Di Nisio, M. | Mulder, F. | +19

CommentIn: Thromb Haemost. 2018 Aug;118(8):1347-1349. - PMID 30060254

6

Edoxaban for the Treatment of Cancer-Associated Venous Thromboembolism

enthalten in: The New England journal of medicine | 2018

von Raskob, G. | van Es, N. | Verhamme, P. | +117

CommentIn: N Engl J Med. 2018 Feb 15;378(7):673-674. - PMID 29443673

7

Prediction of major and clinically relevant bleeding in patients with VTE treated with edoxaban or vitamin K antagonists

enthalten in: Thrombosis and haemostasis | 2017

von Di Nisio, M. | Raskob, G. | Büller, H. | +4

8

Treatment of venous thromboembolism with rivaroxaban in relation to body weight. A sub-analysis of the EINSTEIN DVT/PE studies

enthalten in: Thrombosis and haemostasis | 2016

von Di Nisio, M. | Vedovati, M. | Riera-Mestre, A. | +13

9

Risk of major bleeding in patients with venous thromboembolism treated with rivaroxaban or with heparin and vitamin K antagonists

enthalten in: Thrombosis and haemostasis | 2016

von Di Nisio, M. | Ageno, W. | Rutjes, A. | +2

10

Edoxaban for treatment of venous thromboembolism in patients with cancer. Rationale and design of the Hokusai VTE-cancer study

enthalten in: Thrombosis and haemostasis | 2015

von van Es, N. | Di Nisio, M. | Bleker, S. | +20